SCHEMBL1374559

SCHEMBL1374559

CCCN(CC)C(=O)CCOC(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 4/20 0.41
CA12 O43570 2/20 0.35
CA9 Q16790 2/20 0.35
CA2 P00918 1/20 0.35
TSHR P16473 3/20 0.33
MAPK1 P28482 2/20 0.33
FDPS P14324 1/20 0.33
CA1 P00915 1/20 0.32
MMP1 P03956 1/20 0.31
MMP2 P08253 1/20 0.31
MMP3 P08254 1/20 0.31
MMP8 P22894 1/20 0.31
NPC1 O15118 2/20 0.31
ALOX15 P16050 1/20 0.31
HSD17B10 Q99714 1/20 0.31
HTR1A P08908 1/20 0.31
TP53 P04637 1/20 0.31
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1376920 0.93 ALDH1A1 (0.50) HPGDALDH1A1LMNACA12CA9
SCHEMBL1377034 0.89 LMNA (0.52) HPGDALDH1A1LMNATSHRMAPK1
SCHEMBL1373682 0.86 ALDH1A1 (0.41) HPGDALDH1A1LMNACA12CA9
SCHEMBL16353928 0.82 MMP1 (0.43) HPGDALDH1A1LMNACA12CA9
SCHEMBL1375855 0.81 ALDH1A1 (0.48) HPGDALDH1A1LMNACA12CA9
SCHEMBL1376712 0.80 EPHX2 (0.33) HPGDALDH1A1LMNAFDPSKDM4E
SCHEMBL1373568 0.79 ALDH1A1 (0.47) HPGDALDH1A1LMNACA12CA9
SCHEMBL1374472 0.79 ALDH1A1 (0.47) HPGDALDH1A1LMNACA12CA9
SCHEMBL1377026 0.78 HPGD (0.46) HPGDALDH1A1LMNACA12CA9
SCHEMBL13317119 0.76 ALDH1A1 (0.56) HPGDALDH1A1LMNACA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150119604-A1 METHOD FOR PRODUCING BETA-ALKOXYPROPIONAMIDE IDEMITSU KOSAN CO., LTD. (JP) 2015-04-30 US disclosed
EP-2837619-A1 METHOD FOR PRODUCING BETA -ALKOXYPROPIONAMIDE Idemitsu Kosan Co., Ltd (JP) 2015-02-18 EP disclosed
US-8563495-B2 Resist remover composition and method for removing resist using same IDEMITSU KOSAN CO., LTD. (JP) 2013-10-22 US disclosed
US-20110287995-A1 RESIST REMOVER COMPOSITION AND METHOD FOR REMOVING RESIST USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150119604-A1 METHOD FOR PRODUCING BETA-ALKOXYPROPIONAMIDE HACL2, APEH, NAAA HPGD 1082/4885ALDH1A1 448/4885LMNA 792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.